Howard Hughes Medical Institute’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-309
Closed -$15.7K 202
2025
Q4
$15.7K Hold
309
0.01% 146
2025
Q3
$12.1K Sell
309
-1
-0.3% -$43 0.01% 182
2025
Q2
$13.4K Buy
+310
New +$11.8K 0.01% 162
2014
Q2
Sell
-1,210
Closed -$40K 195
2014
Q1
$40K Sell
1,210
-942
-44% -$31.4K 0.01% 158
2013
Q4
$81K Buy
+2,152
New +$76.3K 0.01% 145

Other funds holding FCX

Howard Hughes Medical Institute's FCX Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of Freeport-McMoran (FCX) in Q1 2026, closing a stake of 309 shares — an estimated $15.7K sold.

Howard Hughes Medical Institute first reported a position in FCX in Q4 2013 and held it in 5 quarters. The position peaked at $81K in Q4 2013. 1,858 funds tracked by Wall St. Rank hold FCX as of Q1 2026.

  • Howard Hughes Medical Institute reported no remaining Freeport-McMoran position as of Q1 2026 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 309 Freeport-McMoran shares in Q1 2026, an estimated $15.7K.
  • Howard Hughes Medical Institute first reported a position in Freeport-McMoran in Q4 2013 and held it in 5 quarters.
  • Howard Hughes Medical Institute's Freeport-McMoran position peaked at $81K in Q4 2013.
  • 1,858 funds tracked by Wall St. Rank held Freeport-McMoran as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.